Abstract
On November 10, 2021, an online meeting of the expert council was held on the conference platform of the First Medical Channel. The subject was “Diarrhea differential diagnosis depending on its pathogenesis in pediatric practice, the role of probiotic medications in its treatment”. Leading Russian experts in the field of clinical pharmacology, gastroenterology, pediatrics, infectious diseases, and allergology-immunology took part in this meeting. As a result of the meeting, the main principles of diagnosis, treatment, and prevention of diarrhea in children were formulated, and an algorithm for using probiotics to treat diarrhea in children was developed. Conclusion. It is preferable to prescribe medicinal probiotics (with registration status) than a dietary supplement containing probiotic bacteria. Medicinal products containing a combination of strains of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12, vitamins B1 and B6, which are approved for use in pediatric practice, are recommended for administration in diarrhea and in suspected antibiotic-associated diarrhea in children, regardless of etiology and pathogenesis, both during the acute period and the next 4 weeks as well as during the entire recovery period (the period of repair and convalescence). Key words: antibiotics, children, diarrhea, treatment, prophylaxis, strain-specific probiotics, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. lactis BB-12
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
